# A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements

> **NCT06258265** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 120 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-279
- **DRUG:** TAK-279 Placebo
- **DRUG:** Moxifloxacin
- **DRUG:** Moxifloxacin Placebo

## Key facts

- **NCT ID:** NCT06258265
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-29
- **Primary completion:** 2024-06-25
- **Final completion:** 2024-07-09
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06258265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06258265, "A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06258265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*